Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.
KMID : 0624620230560070410
BMB Reports
2023 Volume.56 No. 7 p.410 ~ p.415
Anti-migration and anti-invasion effects of LY-290181 on breast cancer cell lines through the inhibition of Twist1
Park Ji-Young

Lee Se-Woong
Yoon Hae-Lim
Kang Eun-Jeong
Cho Sa-Yeon
Abstract
Breast cancer has become the most common cancer among women worldwide. Among breast cancers, metastatic breast cancer is associated with the highest mortality rate. Twist1, one of the epithelial-mesenchymal transition-regulating transcription factors, is known to promote the intravasation of breast cancer cells into metastatic sites. Therefore, targeting Twist1 to develop anti-cancer drugs might be a valuable strategy. In this study, LY-290181 dose-dependently inhibited migration, invasion, and multicellular tumor spheroid invasion in breast cancer cell lines. These anti-cancer effects of LY-290181 were mediated through the down-regulation of Twist1 protein levels. LY-290181 inhibited extracellular signal-regulated kinase and c-Jun N-terminal kinase signaling pathways. Therefore, our findings suggest that LY-290181 may serve as a basis for future research and development of an anti-cancer agent targeting metastatic cancers.
KEYWORD
Breast cancer, EMT, LY-290181, TNBC, Twist1
FullTexts / Linksout information
Listed journal information